BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 28795530)

  • 1. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
    Zhou Y; Han X; Jing X; Chen Y
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the unique functionality of inorganic micro/nanoparticles for versatile ultrasound theranostics.
    Qian X; Han X; Chen Y
    Biomaterials; 2017 Oct; 142():13-30. PubMed ID: 28719818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
    Chen F; Hableel G; Zhao ER; Jokerst JV
    J Colloid Interface Sci; 2018 Jul; 521():261-279. PubMed ID: 29510868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Materials Chemistry of Nanoultrasonic Biomedicine.
    Tang H; Zheng Y; Chen Y
    Adv Mater; 2017 Mar; 29(10):. PubMed ID: 27991697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Material chemistry of graphene oxide-based nanocomposites for theranostic nanomedicine.
    Zhou Y; Jing X; Chen Y
    J Mater Chem B; 2017 Aug; 5(32):6451-6470. PubMed ID: 32264411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose.
    Cheng CA; Chen W; Zhang L; Wu HH; Zink JI
    J Am Chem Soc; 2019 Nov; 141(44):17670-17684. PubMed ID: 31604010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dye-doped silica nanoparticles as luminescent organized systems for nanomedicine.
    Montalti M; Prodi L; Rampazzo E; Zaccheroni N
    Chem Soc Rev; 2014 Jun; 43(12):4243-68. PubMed ID: 24643354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
    Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
    Chen F; Hong H; Goel S; Graves SA; Orbay H; Ehlerding EB; Shi S; Theuer CP; Nickles RJ; Cai W
    ACS Nano; 2015; 9(4):3926-34. PubMed ID: 25843647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine.
    Yang B; Chen Y; Shi J
    Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
    Li L; Liu H
    Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications.
    Liu J; Liu T; Pan J; Liu S; Lu GQM
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-Demand Detaching Nanosystem for the Spatiotemporal Control of Cancer Theranostics.
    Liu T; Wan Q; Luo Y; Chen M; Zou C; Ma M; Liu X; Chen H
    ACS Appl Mater Interfaces; 2019 May; 11(18):16285-16295. PubMed ID: 30986025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
    Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
    Zhang N; Cai X; Gao W; Wang R; Xu C; Yao Y; Hao L; Sheng D; Chen H; Wang Z; Zheng Y
    Theranostics; 2016; 6(3):404-17. PubMed ID: 26909114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliable methods for silica coating of Au nanoparticles.
    Pastoriza-Santos I; Liz-Marzán LM
    Methods Mol Biol; 2013; 1025():75-93. PubMed ID: 23918330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Targeted, Responsive, and Synergistic Cancer Nanotheranostics by Magnetic Resonance Imaging-Guided Synergistic High-Intensity Focused Ultrasound Ablation and Chemotherapy.
    Tang H; Guo Y; Peng L; Fang H; Wang Z; Zheng Y; Ran H; Chen Y
    ACS Appl Mater Interfaces; 2018 May; 10(18):15428-15441. PubMed ID: 29652130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.